These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27900773)

  • 1. Systematic review of immunoglobulin use in paediatric neurological and neurodevelopmental disorders.
    Gadian J; Kirk E; Holliday K; Lim M; Absoud M
    Dev Med Child Neurol; 2017 Feb; 59(2):136-144. PubMed ID: 27900773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.
    Nosadini M; Mohammad SS; Suppiej A; Sartori S; Dale RC;
    Dev Med Child Neurol; 2016 Nov; 58(11):1180-1192. PubMed ID: 27242065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases.
    Bascić-Kes V; Kes P; Zavoreo I; Lisak M; Zadro L; Corić L; Demarin V;
    Acta Clin Croat; 2012 Dec; 51(4):673-83. PubMed ID: 23540178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines on the use of intravenous immune globulin for neurologic conditions.
    Feasby T; Banwell B; Benstead T; Bril V; Brouwers M; Freedman M; Hahn A; Hume H; Freedman J; Pi D; Wadsworth L
    Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S57-107. PubMed ID: 17397768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin treatment of neurological autoimmune diseases.
    Stangel M; Hartung HP; Marx P; Gold R
    J Neurol Sci; 1998 Jan; 153(2):203-14. PubMed ID: 9511879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intravenous immunoglobulin in autoimmune neurological diseases. Literature systematic review and meta-analysis.
    Morales-Ruiz V; Juárez-Vaquera VH; Rosetti-Sciutto M; Sánchez-Muñoz F; Adalid-Peralta L
    Autoimmun Rev; 2022 Mar; 21(3):103019. PubMed ID: 34920107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.
    Elovaara I; Apostolski S; van Doorn P; Gilhus NE; Hietaharju A; Honkaniemi J; van Schaik IN; Scolding N; Soelberg Sørensen P; Udd B;
    Eur J Neurol; 2008 Sep; 15(9):893-908. PubMed ID: 18796075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of IVIg and TPE efficacy in the treatment of neurological disorders: a systematic literature review.
    Pinto AA; De Seze J; Jacob A; Reddel S; Yudina A; Tan K
    Ther Adv Neurol Disord; 2023; 16():17562864231154306. PubMed ID: 37006460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review.
    Fergusson D; Hutton B; Sharma M; Tinmouth A; Wilson K; Cameron DW; Hebert PC
    Transfusion; 2005 Oct; 45(10):1640-57. PubMed ID: 16181216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can we face the challenge of expanding use of intravenous immunoglobulin in neurology?
    Elovaara I; Hietaharju A
    Acta Neurol Scand; 2010 Nov; 122(5):309-15. PubMed ID: 20085560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Lancet; 1997 Jan; 349(9047):225-30. PubMed ID: 9014908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The rational immunotherapy with intravenous immunoglobulin in neurologic diseases].
    Korsak J
    Pol Merkur Lekarski; 2011 Jun; 30(180):430-4. PubMed ID: 21751554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IVIG Versus PLEX in the Treatment of Worsening Myasthenia Gravis: What is the Evidence?: A Critically Appraised Topic.
    Dhawan PS; Goodman BP; Harper CM; Bosch PE; Hoffman-Snyder CR; Wellik KE; Wingerchuk DM; Demaerschalk BM
    Neurologist; 2015 May; 19(5):145-8. PubMed ID: 25970838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin in neurological disorders: a mechanistic perspective.
    Misra N; Bayry J; Ephrem A; Dasgupta S; Delignat S; Duong Van Huyen JP; Prost F; Lacroix-Desmazes S; Nicoletti A; Kazatchkine MD; Kaveri SV
    J Neurol; 2005 May; 252 Suppl 1():I1-6. PubMed ID: 15959666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin in autoimmune neuromuscular diseases.
    Dalakas MC
    JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.
    Lozeron P; Not A; Theaudin M; Denier C; Masnou P; Sarov M; Adam C; Cauquil C; Adams D
    Muscle Nerve; 2016 May; 53(5):683-9. PubMed ID: 26467654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin in the treatment of neurologic disorders.
    Živković S
    Acta Neurol Scand; 2016 Feb; 133(2):84-96. PubMed ID: 25997034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin in neurology--mode of action and clinical efficacy.
    Lünemann JD; Nimmerjahn F; Dalakas MC
    Nat Rev Neurol; 2015 Feb; 11(2):80-9. PubMed ID: 25561275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Patwa HS; Chaudhry V; Katzberg H; Rae-Grant AD; So YT
    Neurology; 2012 Mar; 78(13):1009-15. PubMed ID: 22454268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.